Birth control pill has lasting protective effects against endometrial cancer
the ONA take:
A new study from researchers at the University of Oxford in the United Kingdom reports that oral contraceptives protect against endometrial cancer, and the protective benefit lasts for many years after women stop taking the pills.
Previous studies linked the use of the birth control pill with reduced incidence of endometrial cancer, but whether this continued after the use is discontinued was unknown.
In this study, the researchers used a dataset that included 27,276 women with endometrial cancer and 115,743 women without the disease from 36 epidemiological studies.
They calculated that the risk of endometrial cancer was reduced by approximately 25% for every 5 years of use. Furthermore, the reduced risk persisted for more than 30 years after birth control pills were discontinued.
The decrease in the amount of estrogen birth control pills also did not diminish the protective effects of oral contraceptive use.
An estimated 400,000 cases of endometrial cancer were prevented in developed countries due to the use of birth control pills between 1965 and 2014, with approximately 200,000 cases prevented after 2005.
Oral contraceptives protect against endometrial cancer, and the protective benefit lasts for many years after women stop taking the pills.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|